Radiopharm Theranostics RADX
NASDAQ RADX
$1.42 -0.06 (-4.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Goodwill & Intangibles (2023 - 2026)

Updated

Radiopharm Theranostics' Goodwill & Intangibles came in at $270,702 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 9.2% from $298,278 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Goodwill & Intangibles (2023 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics' Goodwill & Intangibles was $259,179, down 99.4% from FY2025.

  • Goodwill & Intangibles carries a three-year compound annual growth rate of -83.6% (FY2023 to FY2026).
  • Going back by fiscal year, Goodwill & Intangibles was $46.57 million in FY2025, $323,497 in FY2024 (-99.4%) and $58.54 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Radiopharm Theranostics 5.25 Bn 5.21 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 270,701.62
Jun 30, 2025 298,278.06
Dec 31, 2024 48.00 Mn
Jun 30, 2024 323,497.25
Jun 30, 2023 58.54 Mn
API Access

Radiopharm Theranostics Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=RADX&period=max&api_key=YOUR_API_KEY